Luyao Kevin Xu

Luyao Kevin Xu has extensive experience in the biomedical field, currently serving in Drug Discovery at AstraZeneca since 2017. Prior to this role, Luyao Kevin Xu worked at Columbia University Irving Medical Center in Oncology Research from 2011 to 2017 and held an Associate position at Yale University from 2009 to 2011. Academic credentials include studies at Ghent University, The Johns Hopkins University, Columbia University, Yale University, and the University of Toronto.